Literature DB >> 18534439

Liquid gentamicin and vancomycin in bone cement: a potentially more cost-effective regimen.

Pang-Hsin Hsieh1, Ching-Lung Tai, Po-Chen Lee, Yu-Han Chang.   

Abstract

This study investigated the use of liquid gentamicin, a much less costly antibiotic (<1/20 the price of tobramycin) with a broad antimicrobial spectrum, alone and in combination with vancomycin in bone cement. Standardized cement specimens loaded with 480 mg of liquid gentamicin, 4 g of powdered vancomycin, or both antibiotics were tested for elution characteristics, bioactivity, compressive strength, and porosity. Vancomycin elution was enhanced by 146% with the addition of gentamicin liquid, and gentamicin elution was enhanced by 45% when combined with vancomycin. Bioassay confirmed the bactericidal activity of the released antibiotics. Adding liquid gentamicin increased porosity, whereas adding vancomycin did not. Compressive strength decreased by 13%, 37%, and 45% in specimens containing vancomycin, liquid gentamicin, and both antibiotics, respectively. Despite inferior mechanical properties, the temporary nature of cement beads and spacers makes the liquid gentamicin-vancomycin mixture a potentially more cost-effective regimen in bone cement to treat musculoskeletal infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18534439     DOI: 10.1016/j.arth.2008.01.131

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  12 in total

1.  Surfactant-stabilized emulsion increases gentamicin elution from bone cement.

Authors:  Ryan B Miller; Alex C McLaren; Christine M Leon; Brent L Vernon; Ryan McLemore
Journal:  Clin Orthop Relat Res       Date:  2011-11       Impact factor: 4.176

2.  Loading with vancomycin does not decrease gentamicin elution in gentamicin premixed bone cement.

Authors:  Sebastian P Boelch; Martin C Jordan; Joerg Arnholdt; Maximilian Rudert; Martin Luedemann; Andre F Steinert
Journal:  J Mater Sci Mater Med       Date:  2017-05-22       Impact factor: 3.896

3.  Economical analysis on prophylaxis, diagnosis, and treatment of periprosthetic infections.

Authors:  Mariano Fernandez-Fairen; Ana Torres; Ann Menzie; Daniel Hernandez-Vaquero; José Manuel Fernandez-Carreira; Antonio Murcia-Mazon; Enrique Guerado; Luis Merzthal
Journal:  Open Orthop J       Date:  2013-06-14

Review 4.  Antibiotic Elution from Hip and Knee Acrylic Bone Cement Spacers: A Systematic Review.

Authors:  Konstantinos Anagnostakos; Christof Meyer
Journal:  Biomed Res Int       Date:  2017-06-05       Impact factor: 3.411

5.  In vitro study of new combinations for local antibiotic therapy with calcium sulphate - Near constant release of ceftriaxone offers new treatment options.

Authors:  Peter Wahl; Karolin Rönn; Marc Bohner; Laurent A Decosterd; Christoph Meier; Michel Schläppi; Sandrine Festa; Emanuel Gautier
Journal:  J Bone Jt Infect       Date:  2018-10-04

6.  High dose of vancomycin plus gentamicin incorporated acrylic bone cement decreased the elution of vancomycin.

Authors:  Tao Li; Lilan Fu; Jian Wang; Zhanjun Shi
Journal:  Infect Drug Resist       Date:  2019-07-18       Impact factor: 4.003

Review 7.  Controlling Antibiotic Release from Polymethylmethacrylate Bone Cement.

Authors:  Victoria Wall; Thi-Hiep Nguyen; Nghi Nguyen; Phong A Tran
Journal:  Biomedicines       Date:  2021-01-01

Review 8.  Treatment of periprosthetic infections: an economic analysis.

Authors:  Daniel Hernández-Vaquero; Mariano Fernández-Fairen; Ana Torres; Ann M Menzie; José Manuel Fernández-Carreira; Antonio Murcia-Mazon; Enrique Guerado; Luis Merzthal
Journal:  ScientificWorldJournal       Date:  2013-05-28

9.  Liquid antibiotics in bone cement: an effective way to improve the efficiency of antibiotic release in antibiotic loaded bone cement.

Authors:  Y H Chang; C L Tai; H Y Hsu; P H Hsieh; M S Lee; S W N Ueng
Journal:  Bone Joint Res       Date:  2014-08       Impact factor: 5.853

10.  A novel liposomal drug delivery system for PMMA bone cements.

Authors:  Wayne Nishio Ayre; James C Birchall; Samuel L Evans; Stephen P Denyer
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2015-08-10       Impact factor: 3.368

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.